DLGAP1 antisense RNA 4 (non-protein coding) (DLGAP1-AS4)

DLGAP1 antisense RNA 4 (DLGAP1-AS4) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the DLGAP1 locus. It is classified as a non-protein coding transcript and, like other lncRNAs, is likely involved in the regulation of gene expression or chromatin organization, although no peer-reviewed data currently detail its biological function, involvement in disease, or role as a drug target[3]. While other members of the DLGAP1 antisense lncRNA family—such as DLGAP1-AS1—have been implicated in cancer biology and cell signaling processes, there is no definitive information linking DLGAP1-AS4 itself to pathophysiological mechanisms or therapeutic modulation in the literature provided[3]. DLGAP1-AS4 is listed in genetic databases as a lncRNA gene, but there is currently no evidence that it encodes a protein, functions as a receptor, enzyme, or signaling target, or is directly implicated in any disease process, nor is there evidence that it interacts with any drugs or is used as a biomarker[3]. Much research has focused on DLGAP1-AS1 and other family members with substantial cancer relevance, but DLGAP1-AS4 remains uncharacterized in terms of molecular mechanisms or therapeutic targeting[2][4]. By convention, lncRNAs such as DLGAP1-AS4 can regulate gene expression via chromatin modification, mRNA transcript stability, or direct transcriptional interference, but these activities remain speculative for this locus absent direct data[3]. DLGAP1-AS4 is a long non-coding RNA with no confirmed therapeutic, biomarker, or safety relevance, and is not considered a canonical receptor or protein target. Further investigation may be required if new research emerges, but current knowledge restricts its use primarily to basic genetic annotation[3].

Other names

DLGAP1-AS4DLGAP1 antisense RNA 4DLGAP1 antisense RNA 4 (non-protein coding)